Abstract With the introduction of simultaneous PET/MRI scanners, concurrent acquisition of PET and MRI data is feasible, allowing for improved patient convenience and decreased radiation dose. Although PET/MRI has been used in many settings, not all cancers benefit from the combined modality. With the availability of somatostatin receptor-targeted PET tracers such as 68Ga-DOTA-TOC and 68Ga-DOTA-TATE, imaging of NET patients has refocused on targeted imaging, particularly with the development of peptide receptor radiotherapy. Nonetheless, there are many patients who continue to benefit from dedicated MR imaging, such as those with liver-predominant disease. In these patients, SSR PET/MRI is an important option for optimal imaging. Both diffusion-weighted imaging and hepatobiliary phase imaging provide improved lesion detection compared to conventional MRI and CT, and the results can effect therapeutic decisions. Additionally, the use of motion correction techniques can be used to leverage the additional PET data acquired in dedicated liver PET/MRI to remove respiratory artifacts.
PET/MRI             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

hepatobiliary                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatobiliary_system  

disease                       0.9999720565306488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

somatostatin                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Somatostatin          

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

CT                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

tracers                       0.999999998204089^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Radioactive_tracer    

liver                         0.9999999956888814^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liver                 

artifacts                     0.9999788060117186^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Artifact_(error)      

modality                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Medical_imaging       

MRI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_resonance_imaging

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

peptide receptor              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_surface_receptor 

radiation dose                0.9999999999834017^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorbed_dose         

cancers                       0.9999997198699867^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

MRI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_resonance_imaging

concurrent                    0.7675793016504745^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Parallel_computing    

radiotherapy                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Radiation_therapy     

respiratory                   0.909228556709419^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Respiratory_system    

leverage                      0.9992989042608287^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Leverage_(finance)    

diffusion-weighted imaging    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diffusion_MRI         

lesion                        0.9999999999520242^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lesion                

scanners                      0.9999848841240372^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Image_scanner         

NET                           0.9944933923784105^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Norepinephrine_transporter

phase imaging                 0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Phase-contrast_imaging

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

